Inovio Pharmaceuticals Inc vs STMicroelectronics NV — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while STMicroelectronics NV trades at $65.7 (market cap $55.80B). The key difference: STMicroelectronics NV is far larger — about 625.1× Inovio Pharmaceuticals Inc's market cap, and STMicroelectronics NV pays a 0.58% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | STM | |
|---|---|---|
Market Cap | $89.27M | $55.80B |
Sector | Health | Financials |
52-Week High | $2.87 | $79.91 |
52-Week Low | $1.05 | $21.20 |
Enterprise Value | $60.28M | $54.01B |
Dividend Yield | — | 0.58% |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →